Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07762092

1 development in the corpus

NCT07762092

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 13, 2026 · OBSERVATIONAL STUDY

A Post Authorization Registry Study of Participants Treated With LEQEMBI

ClinicalTrials.gov

This is a planned observational registry study with no results yet reported; it will characterize safety and disease progression in routine clinical practice but cannot yet inform clinical decisions.

PreliminaryNCT07762092 Eisai Alzheimers Disease

Reported

Planned enrollment400

Follow-up durationUp to 3 years

Primary outcome measureIncidence and severity of known adverse eve…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support